Average Co-Inventor Count = 3.72
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Chemocentryx, Inc. (10 from 214 patents)
2. Other (1 from 832,347 patents)
3. University of California (1 from 15,331 patents)
11 patents:
1. 11986466 - Methods of treating solid tumors with CCR2 antagonists
2. 11883391 - Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies
3. 11684606 - Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2
4. 11464786 - CXCR7 inhibitors for the treatment of cancer
5. 11304952 - Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor
6. 11207294 - Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2
7. 11154556 - Methods of treating solid tumors with CCR2 antagonists
8. 11045469 - Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies
9. 11020394 - Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C—C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies
10. 10792360 - Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
11. 6245332 - Modulation of systemic memory T cell trafficking